Home » Topics » Conferences

Conferences
RSS

Novel antiparkinsonian agent in development at Kyowa Hakko

June 5, 1997

Merz glycineB antagonists characterized

June 5, 1997

Preclinical and preliminary clinical data on anseculin reported

June 5, 1997

SANG-35 bioequivalent to Neoral in healthy volunteers

June 5, 1997

IL-10 pretreatment of transplant recipients prolongs allograft survival

June 4, 1997

Mechanism of antiproliferative activity of SP-100030 defined

June 4, 1997

Dietary amino acids enhance allograft survival in rats

June 4, 1997

Anti-TAC antibody prevents transplant rejection in phase III

June 4, 1997

Protein tyrosine kinase inhibition as antirejection therapy

June 4, 1997

Basiliximab clinical data presented

June 4, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 11, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Italy’s Angelini pays $4.1B cash for rare disease specialist Catalyst
BioWorld
Italian family-owned Angelini Pharma SpA is making its first move into the U.S. market, acquiring rare diseases specialist Catalyst Pharma Inc. in an all-cash...